Stock info Lifevantage Corp | Filter  Basic-Info

Lifevantage Corp

The company mostly operates in the pharmaceutical sector. The global pharmaceutical companies gained around 75 percent over the period 2006-2016. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 75 percent.

The past year was a profitable year for Lifevantage Corp investors

Over the period from December 2015 till December 2016 the stock gained around 6 percent. Over the past 5 years the stock lost a modest -11,35 percent. Lifevantage Corp's revenues between 2011 and 2015 were quite unstable and moved between 126,18 million dollars and 190,34 million dollars. Lifevantage Corp's net results between 2011 and 2015 were far from constant and moved between -50,79 million dollars and 6,99 million dollars.

The American company didn't pay out any dividends (in the past 5 years).

Lifevantage Corp financed with relatively low debt

Last year the balance sheet of the American company was worth 40,88 million dollars. At the end of 2015 the total debt positon equaled 37,55 million dollars. This is around 91,85 percent of the total balance sheet. The American company's price/earnings-ratio was 18. So the market valued the stock at 18 times the 2015' earnings per share. Many analysts say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

At the end of 2015 the pharmaceutical company's market capitalization (the number of shares times the market price) equaled around 130,51 million dollars. At the end of 2015 the American company had around 13,9 million stocks listed.

All the company's financial reports are available here. More information about Lifevantage Corp can be found it's website. .